An interventional study of Probiotic 1 and Probiotic 2 in IBS, sponsored by Vedic Lifesciences Pvt. Ltd.. Completed at 12 sites in India. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-05.
Sponsored by Vedic Lifesciences Pvt. Ltd. · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
For the current study, the primary outcome is to evaluate the effect of IP on abdominal pain.
The secondary outcome is to assess the effect of IP on IBS-Symptom Severity, IBS-related quality of life, stool form and consistency and on mental status.
Thus providing an effective objective in improving the gut health and symptomatic relief in IBS patients.
This study aims to determine the effect of probiotics, as the investigational products (IPs) in subjects satisfying the Rome IV criteria for IBS. Three hundred and sixty six subjects between 18 to 70 years of age and with a positive diagnosis of Rome IV IBS criteria (IBS-C, D, M and U types) and moderate to severe abdominal pain intensity will be recruited in a multi-center, double-blind, parallel group, placebo-controlled randomized trial.
Vedic Lifesciences Pvt. Ltd. is the lead sponsor of 72 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Hemoglobin (Hb)
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Probiotic 1: A dietary probiotic supplement which contains Bifidobacterium lactis. Dose: \> 10 billion CFU, Frequency: 1 capsule/day, duration: 6 weeks.
Dietary Supplement: Probiotic 1
Probiotic 2: A dietary probiotic supplement which contains Lactobacillus acidophilus. Dose: \> 10 billion CFU, Frequency: 1 capsule/day, duration: 6 weeks.
Dietary Supplement: Probiotic 2
The Placebo contains MCC.
Other: Placebo
The product under investigation is a unique probiotic.
Also known as: Bifidobacterium lactis
The product under investigation is a unique probiotic.
Also known as: Lactobacillus acidophilus
Microcrystalline Cellulose
Change in abdominal pain severity
The change at Day 42 will be assessed by subject dairy.
Time frame: 42 days
Change in abdominal pain severity
The change at Day 21 will be assessed by subject dairy
Time frame: Day 21
Change in IBS symptoms
The change at Day 42 will be compared to baseline
Time frame: Day 42
Change in stool consistency
The change at Day 42 will be compared to baseline by specific questionnaire
Time frame: Day 42
Change in Quality of Life
The change at Day 42 will be compared to baseline by specific questionnaire
Time frame: Day 42
Change in daily number of stools
The change at Day 42 will be compared to baseline
Time frame: Day 42
Ran from Mar 2018 to primary completion in Mar 2019, 11 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Bifidobacterium animalis subsp. lactis · Lacteol
Vedic Lifesciences Pvt. Ltd. →